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Abstract
Background: Chronic increased afterload due to severe aortic stenosis (AS) results in com-
pensatory concentric left ventricular (LV) hypertrophy and LV dysfunction. These in turn 
cause remodeling of the left heart. The aim of this study was to investigate the acute effect of 
transcatheter aortic valve implantation (TAVI) on left atrial (LA) mechanics and LV diastolic 
function.
Methods: The study consisted of a total of 35 consecutive patients (mean age was 77.7 ±  
± 5.0 years, 25 female) undergoing TAVI. All TAVI procedures have been performed under the 
transesophageal echocardiography (TEE) guidance. Before and 24 h after TAVI, all patients 
underwent transthoracic echocardiography (TTE) and mitral inflow velocities with pulsed-
wave (PW) Doppler including early filling wave (E), late diastolic filling wave (A), and E/A 
ratio were obtained. LV diastolic function was also explored by pulsed tissue Doppler imaging 
(TDI). Early (E’) and late (A’) diastolic annular velocities, E’/A’ ratio and E/E’ ratio were 
obtained. In addition, during the procedure before and minutes after the valve implantation, 
the left atrial appendage-peak antegrade flow velocity (LAA-PAFV) was measured and recorded 
with TEE.
Results: Compared with baseline, the mean mitral E, septal E’ and E’/A’ ratio increased 
significantly after TAVI. In addition, the LAA-PAFV increased significantly within minutes 
of TAVI (32.45 ± 10.7 cm/s vs. 47.6 ± 12.6 cm/s, p < 0.001).
Conclusions: TAVI improves LV diastolic function and LA performance immediately.  
(Cardiol J 2016; 23, 4: 449–455)
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Introductıon
Aortic stenosis (AS) is the most commonly 
encountered valvular heart disease requiring 
surgery [1]. The raised pressure overload caused 
by AS, on left ventricle (LV) results in significant 
structural and functional changes, and affects the 
left atrium (LA) even before symptom develop-
ment [2, 3]. Transcatheter aortic valve implantation 
(TAVI) has emerged as a promising alternative to 
surgical aortic valve replacement for patients with 
severe AS and prohibitive or high surgical risk [4]. 
Several studies have already shown the immedi-
ate almost complete normalization in afterload 
and a significant decrease in pressure gradient, 
between the aorta and the LV, as well as clinical 
improvement at short-term follow-ups after TAVI 
[5, 6]. However, so far, its acute impact on LA 
mechanics and LV diastolic function has not been 
demonstrated with the help of intra-procedural 
transesophageal echocardiography (TEE).
In this study, the authors’ objective was to 
determine the acute effect of TAVI on LV diastolic 
function and LA performance, immediately after 
deployment of aortic bioprosthesis.
Methods
Patients
We prospectively enrolled 35 consecutive pa-
tients with severe symptomatic AS who underwent 
TAVI under TEE guidance in our clinic between 
July 2011 and March 2012. Operative risk of all 
patients was calculated based on Logistic European 
System for Cardiac Operative Risk Evaluation 
(EuroSCORE) [7] and the Society of Thoracic 
Surgeon (STS) score [8], and/or clinical judgement. 
Written informed consent of each patient was ob-
tained and the Ethics Committee of our hospital 
approved the study. The decision to proceed with 
TAVI was made by a multidisciplinary heart team 
including invasive cardiologists, cardiovascular 
surgeons, radiologists, and anesthesiologists. Be-
fore the procedure, transthoracic echocardiography 
(TTE), TEE and multi-slice computed tomography 
(MSCT) of the subjects were performed to evaluate 
the convenience and technique of TAVI.
Transthoracic echocardiography  
and Doppler measurements
All patients underwent a comprehensive con-
ventional TTE with 2-dimensional (2D), M-mode and 
Doppler assessment (IE33 echocardiography sys-
tem, Philips Medical Systems, Eindhoven, the Neth-
erlands) before the TAVI procedure. For all meas-
urements, 3 beats in patients with sinus rhythm and 
5 beats in patients with atrial fibrillation (AF) were 
stored and off-line processed. All echocardiographic 
data were analyzed at the end of the data collec-
tion. Mean transvalvular gradient was calculated 
with Bernoulli formula and aortic valve area was 
measured by the continuity equation. Severe AS 
was defined as a mean transaortic pressure gradi-
ent > 40 mm Hg or aortic valve area < 1 cm2 [9]. 
LV ejection fraction was calculated from apical 
views using the biplane Simpson’s method. LV 
mass (LVM) was calculated by Devereux formula 
[10] and LVM index (LVMI) was calculated by 
dividing LVM by body surface area using Mostel-
ler formula [11]. LV hypertrophy was defined as 
LVMI > 95 g/m2 for women and LVMI > 115 g/m2 
for men. LA enlargement was determined by LA 
volume that was estimated by biplane 2D echocar-
diography using the modified Simpson’s rule [12]. 
Normal LA volume indexed to body surface area 
was defined as < 34 mL/m2 and LA enlargement 
was considered over this value.
To assess LV diastolic function from the be-
ginning to the end of the procedure, modified 
American Society of Echocardiography recom-
mendations with the use of the tissue Doppler 
parameters were used [13]. Pulsed-wave (PW) 
Doppler was performed in the apical 4-chamber 
view to obtain mitral inflow velocities to assess 
LV diastolic function. A 1-mm to 3-mm sample 
volume was placed between mitral leaflet tips 
during diastole, as recommended [13]. Measure-
ments of mitral inflow included the peak of early 
filling wave (E), late diastolic filling wave (A) and 
the E/A ratio were obtained. LV diastolic func-
tion was also explored by pulsed tissue Doppler 
imaging (TDI), placing the sample volume at the 
level of mitral lateral and septal annulus from the 
apical 4-chamber view [14]. Early (E’) and late (A’) 
diastolic annular velocities were obtained. The 
E’/A’ ratio was used as load-independent marker 
of LV diastolic relaxation [15]. The A and A’ waves 
could not be obtained in patients with AF. There-
fore E/A, E’/A’, and septal A’ were measured in 
25 patients. The E/E’ ratio was also obtained as 
a reliable index of LV filling pressures [16].
Transcatheter aortic valve implantation
Transcatheter aortic valve implantation was 
performed at the catheterization laboratory with 
fluoroscopy and TEE guidance and all under gen-
eral anesthesia using conventional technique. Thir-
ty-four (97%) patients through femoral artery and 
450 www.cardiologyjournal.org
Cardiology Journal 2016, Vol. 23, No. 4
1 (3%) patient through subclavian artery received 
a balloon expandable Edwards SAPIEN (Edwards 
Lifesciences, Irvine, CA, USA) aortic valve. The 
sizes of the valves used were 23 mm and 26 mm and 
it was decided with combined multimodal imaging 
methods like TTE, TEE and MCST.
Transesophageal echocardiography  
measurements
During the procedure, left atrial appendage-
peak antegrade flow velocity (LAA-PAFV) with 
TEE (IE33 echocardiography system, X7-2t probe, 
7 MHz, Philips Medical Systems, Eindhoven, the 
Netherlands) was measured and recorded. TEE 
was performed just before the intervention and it 
was repeated few minutes after the valve deploy-
ment (4.8 ± 1.7 min) to compare between TEE 
results before and after TAVI. PW spectral Doppler 
was recorded in mid-esophageal basal short-axis 
view at aortic valve level (30–60°) to assess the 
LAA-PAFV which was calculated by placing PW 
Doppler cursor in the LAA 2 mm from its orifice 
(Fig. 1). In sinus rhythm, LAA-PAFV was calculated 
as the average of the 3 highest velocities, whereas 
in patients with AF, the average of 5 cardiac cycles 
was used.
After the valve implantation, the presence of 
complications like cardiac effusion or tamponade, 
aortic regurgitation, valve displacement, LV wall 
motion abnormalities, and mitral valve injury were 
described [17]. Data expected to interfere with 
diastolic function parameters like systolic or dias-
tolic blood pressure, heart rate, and hemoglobin 
level were assessed before the procedure and few 
minutes after the valve deployment.
Statistical analysis
Statistics were calculated using SPSS version 
19.0 (IBM Corporation, Armonk, NY). Categori-
cal variables were expressed as percentages and 
continuous variables as mean (standard devia-
tion). A multivariate covariance analysis was also 
performed to evaluate the influence of potential 
confounders on main outcome variables. A prob-




The baseline characteristic features of the 
patients were presented in Table 1. Of the consecu-
tive 35 study patients, 25 (71.4%) were female. 
The mean age was 77.7 ± 5.0 years. The mean 
body mass index was 30.0 ± 10.6 kg/m2. Twenty-
-eight point six percent of patients had AF and 42% 
of patients had chronic renal failure (defined as 
glomerular filtration rate < 60 mL/min/1.73 m2) 
before the procedure. Also, pulmonary hyperten-
sion (defined as systolic pulmonary artery pressure 
> 40 mm Hg) was present in 48% of patients. Ac-
cording to the New York Heart Association classifi-
cation, 74.3% of patients were in functional class III. 
The valve was successfully deployed in all patients.
Conventional transthoracic and 
transesophageal echocardiography
All standard echocardiographic findings were 
shown in Table 2. After the valve deployment, the 
peak and mean transaortic systolic gradients, effec-
tive orifice area, and LV ejection fraction improved 
Figure 1. Left atrial appendage peak antegrade flow velocity measured during the procedure before (A) and minutes 
after (B) transcatheter aortic valve implantation with help of transesophageal echocardiography.
A B
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significantly. There were no statistically significant 
differences between the baseline examination 
and the examination after TAVI regarding LVMI, 
A wave, E/A ratio, septal A’, and E/E’ ratio. However, 
the parameters indicating early diastolic LV filling 
improved significantly: mean E (1.0 ± 0.38 m/s vs. 
1.2 ± 0.34 m/s, respectively, p = 0.003) and septal 
E’ (5.4 ± 1.7 cm/s vs. 6.9 ± 2.4 cm/s, respectively, 
p = 0.001) increased. Furthermore, the load-inde-
pendent marker of ventricular diastolic relaxation, 
E’/A’ ratio increased significantly as well (0.76 ± 
± 0.21 vs. 1.02 ± 0.42, respectively, p < 0.001).
When we analyzed the LAA-PAFV measured 
during the procedure with the help of TEE before 
and minutes after TAVI, we realized that it has 
been significantly improved after valve deploy-
ment (32.45 ± 10.7 cm/s vs. 47.6 ± 12.61 cm/s, 
respectively, p < 0.001). In order to assess the 
influence of potential confounders on main out-
come variables, a multivariate covariance analysis 
was performed. We found a significant increase in 
the E wave and LAA-PAFV in the study popula-
tion (Table 3).
Discussion
In long-standing severe AS, a time-related 
structural and histologic remodeling occurs both 
in the LV, LA, and thereafter in the LAA. LV dias-
tolic dysfunction caused by AS is well established 
[18, 19] and is related with LA dilatation which is 
assumed an indicator of severity and chronicity 
of diastolic dysfunction, as well as the magnitude 
of LA pressure rise [20–22]. During the diastolic 
period of left heart, the LA is directly exposed to 
LV pressure through the open mitral valve, thus it 
is affected by the chronic pressure rise resulting 
in increased LV filling pressures [23]. Therefore, 
many studies to date have come to the conclusion 
that the state of LA reflects the diastolic function 
of the LV [24, 25]. LA dysfunction in AS has been 
shown to predict mortality, indirectly enforcing the 
significance of raised LA pressure on the clinical 
outcome of patients with AS [26].
Decreased velocities of LAA in patients with 
AS can be observed in the presence of elevated LA 
pressure [27]. In addition, conditions that increase 
the LV filling pressure like AS impairs LAA flow 
[28]. Likewise, in patients with disturbed diastolic 
function, increasing LV end-diastolic pressure and 
LA pressure give rise to decrease in antegrade 
flow velocities of LAA [29]. Due to this fact, the 
loss of contractile elements of LAA may result in 
its reduced mechanical function which could be 
expressed in low LAA flow velocity profile. Various 
studies have proven LAA-PAFV to be a valuable 
means by which the structure and function of the 
LA may be predicted. More specifically, the stud-
ies have claimed that larger LA and LAA sizes are 
associated with lower LAA flow velocity [30]. TEE 
is the most widely used method for the evaluation 
of the LAA morphology and flow patterns within it. 
Therefore, in this study, we have used intra-proce-
dural TEE to assess LAA-PAFV and we observed 
a significant increase in LAA-PAFV minutes after 
TAVI. Thus, we concluded that TAVI improves LA 
performance and this in turn improves LV diastolic 
function immediately.
Table 1. Baseline characteristic features of the 
patients.
Variables N = 35
Age [years] 77.7 ± 5.0
Female 71.4%
Body mass index [kg/m2] 30.0 ± 10.6
Logistic EuroSCORE [%] 18.1 ± 13.7























*Grading concerns only the patients with sinus rhythm; CABG —  
coronary artery bypass grafting; COPD — chronic obstructive 
pulmonary disease; EuroSCORE — European System for Cardiac 
Operative Risk Evaluation; LA — left atrial; LV — left ventricular; 
NYHA — New York Heart Association; PCI — percutaneous coro-
nary intervention; STS — Society of Thoracic Surgeons
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After TAVI, almost complete normalization 
of LV afterload occurs without significant vari-
ability among patients [5, 6]. Normalization of 
LV diastolic function [31] and benefit in ejection 
fraction, volumes, and hypertrophy are observed 
at long-term follow-up [32]. Gotzmann et al. [33] 
have determined improvement in diastolic function 
at 6-month follow-up in patients undergoing TAVI 
with CoreValve prosthesis.
The significant increase in LV E, E’, and E’/A’ 
ratio observed 24 h after TAVI and also significant 
increase in LAA-PAFV minutes after TAVI may 
Table 2. Conventional echocardiographic results before and after the procedure (n = 35).
Variables Baseline After TAVI P
Transthoracic echocardiographic variables
Aortic valve
Maximum systolic gradient [mm Hg] 87.2 ± 20.3 18.2 ± 4.3 < 0.001
Mean systolic gradient [mm Hg] 54.1 ± 15.1 9.1 ± 2.4 < 0.001
Effective orifice area [cm2] 0.62 ± 0.16 2.0 ± 0.28 < 0.001
Left ventricular ejection fraction [%] 54.4 ± 12.7 57.5 ± 9.6 0.039
Left ventricular mass index [g/m2] 137.9 ± 34.5 138.4 ± 28.5 0.881




E [m/s] 1.0 ± 0.38 1.2 ± 0.34 0.003
A† [m/s] 0.91 ± 0.36 0.92 ± 0.4 0.491
E/A† ratio 1.19 ± 0.6 1.2 ± 0.6 0.815
Septal E’ [cm/s] 5.4 ± 1.7 6.9 ± 2.4 0.001
Septal A’† [cm/s] 7.1 ± 3.8 6.7 ± 3.2 0.641
E’/A’† ratio 0.76 ± 0.21 1.02 ± 0.42 < 0.001
E/E’ ratio 20.1 ± 8.1 20.9 ± 7.5 0.718
Transesophageal echocardiographic variables
Degree of aortic regurgitation [%]: NS
Absent or mild 77.2 94.3
Medium 20 5.7
Severe 2.8 None
Mean LAA-PAF [cm/s] 32.45 ± 10.7 47.6 ± 12.6 < 0.001
†Evaluated only in patients with sinus rhythm; A — atrial flow velocity; A’ — peak late diastolic velocity; E — mitral peak early diastolic veloc-
ity; E’ — peak early diastolic velocity; LAA-PAF — left atrial appendage peak antegrade flow
Table 3. Covariance multivariate analysis of clinical parameters during the procedure (n = 35).
Variables Baselinea Minutes after TAVIa Difference of means (95% CI) P
E wave [m/s] 1.00 (0.88; 1.12) 1.09 (0.9; 1.2) 0.09 (–0.17; 0.03) < 0.001b
LAA-PAF [cm/s] 32.4 (28.7; 36.1) 47.6 (43.2; 51.9) 15.2 (–18.4; –11.7) < 0.001b
E/A ratio 1.19 (0.91; 1.47) 1.24 (0.9; 1.5) 0.05 (–0.38; 0.30) 0.143
Septal E’ [cm/s] 0.052 (0.048; 0.057) 0.053 (0.050; 0.057) 0.001 (–0.006; 0.003) 0.052
E/E’ ratio 20.1 (17.3; 22.9) 20.9 (18.3; 23.6) 0.08 (–3.35; 2.33) 0.718
E’/A’ ratio 0.76 (0.68; 0.84) 1.02 (0.93; 1.12) 0.26 (–0.32; –0.14) < 0.001
aData presented as adjusted mean (95% confidence interval); bUnivariate — none of the confounder had a significant effect on the mean  
E wave and mean LAA-PAF variation during the procedure; LAA-PAF — left atrial appendix-peak antegrade flow
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imply an immediate improvement of LV diastolic 
function in our study. The increase in maximum E 
velocity may be explained by alterations in preload 
or in LV relaxation. The augmented LA-LV pres-
sure during early diastole and the augmented E 
wave, are the consequence of an ameliorated LV 
relaxation, in response to immediate, complete and 
sustained afterload release.
Bauer et al. [34] demonstrated an increase in 
E’ and A’ measured by pulsed TDI in LV septal wall 
but no difference in LV diastolic function measured 
by blood flow Doppler echocardiography when they 
examined the patients 24 h post-procedurally. After 
TAVI, our patients showed significant increases in 
effective orifice area and marked decreases in trans-
valvular pressure gradients, equivalent to a reduction 
in LV afterload [35]. In addition, E and E’ increased 
significantly after TAVI. These results are consist-
ent with previously published data from Gonçalves 
et al. [35] and Guarracino et al. [36], who measured 
LV relaxation parameters within minutes of TAVI.
Our main findings were those of immediate 
improvement of LV diastolic function and increase 
in LA hemodynamics in the minutes of valve 
deployment. TAVI gives rise to a unique oppor-
tunity regarding the assessment of LV diastolic 
function immediately after afterload release and 
the observed improvement is in concert with the 
expectations from the Frank-Starling law.
This study is, to the best of our knowledge, the 
first to examine the early recovery of LV diastolic 
function and LA performance after TAVI through 
comprehensive interpretation of echocardiographic 
findings including LAA-PAFV with TEE. We ob-
served that after the release of chronic pressure 
overload with TAVI, an immediate improvement 
has occurred in diastolic function of the left heart. 
Our results shed light on the direct relationship 
between the mechanical function of LAA, LA and 
LV diastolic function in patients with severe AS.
Limitations of the study
The main limitation of our study is the limited 
number of patients. The reason for relatively small 
number of the patients conducted into our study is 
that we performed TAVI only to the first 35 patients 
with TEE. After that, due to no need for TEE guid-
ance, other patients underwent TAVI without it.
Conclusions
From these results we concluded that LA and 
LAA functions decrease in patients with severe 
AS and LV diastolic dysfunction. TAVI results in 
early recovery of LA performance and LV diastolic 
function immediately after relieving LV afterload. 
An acute rise in LAA peak antegrade flow velocity 
is associated with improvement of LA mechanics 
and LV diastolic function. However, whether our 
results are persistent or transient is unknown and 
they should be evaluated with large scale studies.
Conflict of interest: None declared
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